Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Fengdan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Ferroptosis, HMGB1 Protein, Reperfusion Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Natural Science Foundation of Ningbo.
Abstract (Originalsprache)
Ischemia/reperfusion (I/R) of skeletal muscle in the lower limbs is an important factor affecting the outcome of lower limbs ischemia patients, with no effective preventive or therapeutic approaches available. The study was to investigate the effect of syringic acid (SA) on I/R skeletal muscle in the lower limbs injury. Mice femoral artery I/R models and C2C12 cell hypoxia/reoxygenation (H/R) models was establish, tissue damage, inflammatory status, and high mobility group box 1 (HMGB1) pathway were evaluated using histological analysis, enzyme‐linked immunosorbent assay, and western blotting. Further, the study detected the effect of SA on cell apoptosis, lipid peroxidation, Fe 2+ level, and ferroptosis‐related proteins expression. Finally, the effect of HMGB1 expression on SA in H/R stimulation was studied. SA alleviated pathological damage and reduced levels of IL‐1β, IL‐6, and TNF‐α in muscle tissues from femoral artery I/R mouse models. SA upregulated Bcl‐2 and SOD as well as downregulated Bax, MDA, TBARS content, and Fe 2+ level in H/R‐induced cells. SA inhibited HMGB1 expression and promoted Nrf2, HO‐1, GPX4, and SLC7A11 expressions in the injured tissues and cells. Such effects of SA on H/R‐induced cells were rescued by HMGB1 overexpression. SA suppressed ferroptosis of skeletal muscle cells to alleviate lower limb I/R injury in mice by blocking the HMGB1 pathway, providing new insights for the treatment of lower limb ischemia–reperfusion injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Surgery Department, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Förderung
- Natural Science Foundation of Ningbo
Zitieren
APA
Wang, F., Qi, Y., Gao, Y., Wang, Z., Shen, X., & Wu, H. (2023). Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14326
Vancouver
Wang F, Qi Y, Gao Y, Wang Z, Shen X, Wu H. Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14326
BibTeX
@article{Wang2023,
author = {Wang, Fengdan and Qi, Yanqing and Gao, Yakun and Wang, Zhifang and Shen, Xiaowei and Wu, Hongyu},
title = {Syringic acid suppresses ferroptosis of skeletal muscle cells to alleviate lower limb ischemia/reperfusion injury in mice via the HMGB1 pathway},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14326}
}
EUVIMED